UrOops3D, danger-zone atlas
UP-023 adult elective · day-case · inpatient
Uro-oncology

Immediate intravesical chemotherapy after bladder tumour resection

A protocol-governed single bladder instillation of cytotoxic therapy soon after selected TURBT, only when resection findings and bladder integrity make instillation appropriate.

core 3 recorded variations 7 complication modules Also: single immediate instillation · post-TURBT intravesical chemotherapy · SI chemotherapy
Rendered frame from the Interactive immediate mitomycin model Interactive 3D Interactive immediate mitomycin model Open the 3D animation

Teaching catalogue only. This coverage record is not a patient pathway or operative instruction.

Click me next Explore Animation →

Typical place in practice

Reduction of early tumour-cell reimplantation and recurrence risk in appropriately selected non-muscle-invasive bladder cancer pathways.

Alternatives and neighbouring procedures

Omission when contraindicated, irrigation pathways or later risk-adapted intravesical therapy according to pathology and guideline stratification.

Same procedure family, explicit technique branches

These are variations of this canonical operation. Complication modules below identify whether they apply to all branches or only to named approaches.

01 · Postoperative catheter instillation

Recovery-area immediate instillation

The agent is delivered through a confirmed bladder catheter after operative findings are reviewed.

02 · End-of-procedure catheter instillation

Theatre immediate instillation

The instillation occurs within the operative workflow once haemostasis and bladder integrity are judged suitable.

03 · Protocol-controlled catheter system

Closed-system intravesical delivery

A closed handling and drainage pathway limits staff and environmental exposure.

High-level sequence

Coverage outline only; not a step-by-step technical guide.

  1. Verify eligibility against pathology intent and operative findings
  2. Explicitly exclude suspected perforation, major bleeding or unsafe catheter position
  3. Confirm agent, patient and closed handling pathway
  4. Instil and retain according to the local authorised protocol
  5. Drain or release safely and document exposure, tolerance and exceptions

Every failure mode is its own module.

Timing and variation coverage are recorded for each module.

Open in complication index
C01
early injury

Extravasation with chemical tissue injury

Instillation through a perforated bladder or misplaced catheter can expose perivesical tissues to a cytotoxic agent and cause severe local injury.

Applies to: Recovery-area immediate instillation · Theatre immediate instillation · Closed-system intravesical delivery
C02
early functional

Chemical cystitis, urgency or pain

Urothelial irritation can cause dysuria, frequency, urgency, bladder spasm and pelvic pain.

Applies to: Recovery-area immediate instillation · Theatre immediate instillation · Closed-system intravesical delivery
C03
early bleeding

Haematuria or clot-related drainage failure

A bleeding resection bed may worsen symptoms, block the catheter and complicate safe agent removal.

Applies to: Recovery-area immediate instillation · Theatre immediate instillation · Closed-system intravesical delivery
C04
early infection

Urinary infection

Instrumentation and catheter manipulation can contribute to infection after TURBT.

Applies to: Recovery-area immediate instillation · Theatre immediate instillation · Closed-system intravesical delivery
C05
immediate systemic

Systemic or hypersensitivity reaction

Unexpected absorption or agent sensitivity may produce systemic symptoms requiring recognition beyond routine bladder discomfort.

Applies to: Recovery-area immediate instillation · Theatre immediate instillation · Closed-system intravesical delivery
C06
immediate systemic

Occupational or environmental exposure

Leaks, disconnections and unsafe disposal can expose staff, carers or the environment to cytotoxic material.

Applies to: Recovery-area immediate instillation · Theatre immediate instillation · Closed-system intravesical delivery
C07
immediate oncological quality

Wrong-patient, wrong-agent or protocol deviation

A selection, identification, timing or documentation failure can create direct harm and undermine the intended oncological pathway.

Applies to: Recovery-area immediate instillation · Theatre immediate instillation · Closed-system intravesical delivery

Sources for this module